Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials

BACKGROUND: Controlled studies and observational studies have shown that sodium-glucose cotransporter type 2 inhibitors (SGLT-2i) are beneficial for the survival of patients with heart failure (HF). However, it is unclear whether SGLT-2i can provide benefit in patients with other cardiovascular dise...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cardiovasc Diabetol
Main Authors: Zheng, Caiyun, Lin, Meimei, Chen, Yan, Xu, Haiting, Yan, Lingqun, Dai, Hengfen
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2021
Fag:
Original Investigation
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8063441/
https://ncbi.nlm.nih.gov/pubmed/33888126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-021-01272-z
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker